Literature DB >> 27427828

Multitasking Human Lectin Galectin-3 Interacts with Sulfated Glycosaminoglycans and Chondroitin Sulfate Proteoglycans.

Melanie L Talaga1, Ni Fan1, Ashli L Fueri1, Robert K Brown1, Purnima Bandyopadhyay1, Tarun K Dam1.   

Abstract

Glycosaminoglycan (GAG) binding proteins (GAGBPs), including growth factors, cytokines, morphogens, and extracellular matrix proteins, interact with both free GAGs and those covalently linked to proteoglycans. Such interactions modulate a variety of cellular and extracellular events, such as cell growth, metastasis, morphogenesis, neural development, and inflammation. GAGBPs are structurally and evolutionarily unrelated proteins that typically recognize internal sequences of sulfated GAGs. GAGBPs are distinct from the other major group of glycan binding proteins, lectins. The multifunctional human galectin-3 (Gal-3) is a β-galactoside binding lectin that preferentially binds to N-acetyllactosamine moieties on glycoconjugates. Here, we demonstrate through microcalorimetric and spectroscopic data that Gal-3 possesses the characteristics of a GAGBP. Gal-3 interacts with unmodified heparin, chondroitin sulfate-A (CSA), -B (CSB), and -C (CSC) as well as chondroitin sulfate proteoglycans (CSPGs). While heparin, CSA, and CSC bind with micromolar affinity, the affinity of CSPGs is nanomolar. Significantly, CSA, CSC, and a bovine CSPG were engaged in multivalent binding with Gal-3 and formed noncovalent cross-linked complexes with the lectin. Binding of sulfated GAGs was completely abolished when Gal-3 was preincubated with β-lactose. Cross-linking of Gal-3 by CSA, CSC, and the bovine CSPG was reversed by β-lactose. Both observations strongly suggest that GAGs primarily occupy the lactose/LacNAc binding site of Gal-3. Hill plot analysis of calorimetric data reveals that the binding of CSA, CSC, and a bovine CSPG to Gal-3 is associated with progressive negative cooperativity effects. Identification of Gal-3 as a GAGBP should help to reveal new functions of Gal-3 mediated by GAGs and proteoglycans.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27427828     DOI: 10.1021/acs.biochem.6b00504

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  A capture and release method based on noncovalent ligand cross-linking and facile filtration for purification of lectins and glycoproteins.

Authors:  Christina J Welch; Melanie L Talaga; Priyanka D Kadav; Jared L Edwards; Purnima Bandyopadhyay; Tarun K Dam
Journal:  J Biol Chem       Date:  2019-12-02       Impact factor: 5.157

Review 2.  From Inflammation to Fibrosis-Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities.

Authors:  Navin Suthahar; Wouter C Meijers; Herman H W Silljé; Rudolf A de Boer
Journal:  Curr Heart Fail Rep       Date:  2017-08

Review 3.  Biological roles of glycans.

Authors:  Ajit Varki
Journal:  Glycobiology       Date:  2016-08-24       Impact factor: 4.313

4.  Proteomic identification of galectin-11 and 14 ligands from Haemonchus contortus.

Authors:  Dhanasekaran Sakthivel; Jaclyn Swan; Sarah Preston; M D Shakif-Azam; Pierre Faou; Yaqing Jiao; Rachael Downs; Harinda Rajapaksha; Robin Gasser; David Piedrafita; Travis Beddoe
Journal:  PeerJ       Date:  2018-03-19       Impact factor: 2.984

5.  Locally anchoring enzymes to tissues via extracellular glycan recognition.

Authors:  Shaheen A Farhadi; Evelyn Bracho-Sanchez; Margaret M Fettis; Dillon T Seroski; Sabrina L Freeman; Antonietta Restuccia; Benjamin G Keselowsky; Gregory A Hudalla
Journal:  Nat Commun       Date:  2018-11-22       Impact factor: 14.919

6.  Mapping glycan-mediated galectin-3 interactions by live cell proximity labeling.

Authors:  Eugene Joeh; Timothy O'Leary; Weichao Li; Richard Hawkins; Jonathan R Hung; Christopher G Parker; Mia L Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-16       Impact factor: 11.205

Review 7.  Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update.

Authors:  Navin Suthahar; Wouter C Meijers; Herman H W Silljé; Jennifer E Ho; Fu-Tong Liu; Rudolf A de Boer
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

Review 8.  Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z.

Authors:  Salvatore Sciacchitano; Luca Lavra; Alessandra Morgante; Alessandra Ulivieri; Fiorenza Magi; Gian Paolo De Francesco; Carlo Bellotti; Leila B Salehi; Alberto Ricci
Journal:  Int J Mol Sci       Date:  2018-01-26       Impact factor: 5.923

9.  Galectin-3 Regulates the Expression of Tumor Glycosaminoglycans and Increases the Metastatic Potential of Breast Cancer.

Authors:  Jonathas Xavier Pereira; Sofia Nascimento Dos Santos; Thaís Canuto Pereira; Mariana Cabanel; Roger Chammas; Felipe Leite de Oliveira; Emerson Soares Bernardes; Márcia Cury El-Cheikh
Journal:  J Oncol       Date:  2019-12-17       Impact factor: 4.375

10.  Structural insight into the binding of human galectins to corneal keratan sulfate, its desulfated form and related saccharides.

Authors:  Michelle C Miller; Chao Cai; Kanin Wichapong; Sayantan Bhaduri; Nicola L B Pohl; Robert J Linhardt; Hans-Joachim Gabius; Kevin H Mayo
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.